We are live on ! Find out more
DWA

Dorsey Wright & Associates Portfolio holdings

AUM $590M
1-Year Est. Return 77.57%
This Fund
S&P 500
This Quarter Est. Return
+9.02%
1 Year Est. Return
+77.57%
3 Year Est. Return
+310.64%
5 Year Est. Return
10 Year Est. Return
AUM
$549M
AUM Growth
-$132M
Cap. Flow
-$157M
Cap. Flow %
-28.53%
Top 10 Hldgs %
20.95%
Holding
324
New
207
Increased
12
Reduced
69
Closed
36

Top Buys

Rank Stock Value
1
AER icon
AerCap
AER
+$6.49M
2
LOGI icon
Logitech
LOGI
+$6.36M
3
ZTO icon
ZTO Express
ZTO
+$6.32M
4
TTE icon
TotalEnergies
TTE
+$6.24M
5
SHPG
Shire pic
SHPG
+$6.22M

Sector Composition

Rank Sector Weight
1 Technology 17.08%
2 Healthcare 16.56%
3 Energy 10.16%
4 Consumer Discretionary 9.21%
5 Industrials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OOMA icon
201
Ooma
OOMA
$574M
$16K ﹤0.01%
+937
New +$15K
RCKT icon
202
Rocket Pharmaceuticals
RCKT
$367M
$16K ﹤0.01%
+640
New +$13.9K
TRUP icon
203
Trupanion
TRUP
$1.36B
$16K ﹤0.01%
+460
New +$17.8K
XENE icon
204
Xenon Pharmaceuticals
XENE
$6.21B
$16K ﹤0.01%
+1,184
New +$13.7K
KIN
205
DELISTED
Kindred Biosciences, Inc.
KIN
$16K ﹤0.01%
+1,129
New +$15.3K
BFYT
206
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$16K ﹤0.01%
+263
New +$12K
CRCM
207
DELISTED
CARE.COM, INC.
CRCM
$16K ﹤0.01%
+715
New +$14.3K
XOXO
208
DELISTED
Xo Group Inc
XOXO
$16K ﹤0.01%
+465
New +$14.4K
MEET
209
DELISTED
The Meet Group, Inc. Common Stock
MEET
$16K ﹤0.01%
+3,264
New +$14.6K
ATTU
210
DELISTED
Attunity Ltd
ATTU
$16K ﹤0.01%
+872
New +$14.8K
AMRC icon
211
Ameresco
AMRC
$1.47B
$15K ﹤0.01%
+1,070
New +$14.6K
AVTX icon
212
Avalo Therapeutics
AVTX
$1.04B
$15K ﹤0.01%
+1
New +$13.1K
CMTL icon
213
Comtech Telecommunications
CMTL
$52.7M
$15K ﹤0.01%
+415
New +$14.2K
MRKR icon
214
Marker Therapeutics
MRKR
$18.5M
$15K ﹤0.01%
+163
New +$14K
OPY icon
215
Oppenheimer Holdings
OPY
$1.23B
$15K ﹤0.01%
+470
New +$14.5K
RCKY icon
216
Rocky Brands
RCKY
$353M
$15K ﹤0.01%
+543
New +$15.8K
SLP icon
217
Simulations Plus
SLP
$370M
$15K ﹤0.01%
+720
New +$14.1K
VSTM icon
218
Verastem
VSTM
$604M
$15K ﹤0.01%
+174
New +$17.3K
CDMO
219
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$15K ﹤0.01%
+2,202
New +$13.1K
QTNT
220
DELISTED
Quotient Limited Ordinary Shares
QTNT
$15K ﹤0.01%
+50
New +$15K
DRNA
221
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$15K ﹤0.01%
+975
New +$14.2K
VSLR
222
DELISTED
VIVINT SOLAR, INC.
VSLR
$15K ﹤0.01%
+2,943
New +$15.6K
CARO
223
DELISTED
Carolina Financial Corp.
CARO
$15K ﹤0.01%
+400
New +$16.6K
ARQL
224
DELISTED
Arqule Inc
ARQL
$15K ﹤0.01%
+2,625
New +$14.9K
ASNA
225
DELISTED
Ascena Retail Group, Inc.
ASNA
$15K ﹤0.01%
+164
New +$13.6K

Similar funds

Dorsey Wright & Associates's Q3 2018 Portfolio in Review

As of Q3 2018, Dorsey Wright & Associates held 324 positions worth $549M, down 19% from $681M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Dorsey Wright & Associates withdrew a net $157M in Q3 2018, closing 36 positions and reducing 69 holdings. Its most notable exit was Edenor, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Dorsey Wright & Associates opened a new position in AerCap worth $6.61M.

  • Dorsey Wright & Associates's largest Q3 2018 buy was AerCap: 114,870 shares worth $6.61M.
  • Dorsey Wright & Associates added most to Bio-Rad Laboratories Class A in Q3 2018, an estimated $4.67M increase.
  • Dorsey Wright & Associates's biggest Q3 2018 reduction was TAL Education Group, cutting an estimated $9.71M.
  • Dorsey Wright & Associates fully exited Edenor in Q3 2018, selling an estimated $15.9M.
  • Dorsey Wright & Associates's ten largest holdings make up 21% of its $549M portfolio in Q3 2018.
  • Dorsey Wright & Associates opened 207 new positions and closed 36 in Q3 2018.
  • Dorsey Wright & Associates's portfolio value fell 19% quarter-over-quarter to $549M.

Based on Dorsey Wright & Associates's 13F filing for Q3 2018, filed 12 Oct 2018.